Journal of Shandong University (Health Sciences) ›› 2018, Vol. 56 ›› Issue (6): 21-28.doi: 10.6040/j.issn.1671-7554.0.2017.875

Previous Articles     Next Articles

Cooperative pH-sensitivity polyion complex micelles for co-delivery of doxorubicin and paclitaxel

ZHU Yixin, FAN Xiaohui, CHEN Yan, LI Lingbing   

  1. Department of Pharmaceutics, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China
  • Published:2022-09-27

PDF (PC)

36

Abstract: Objective To achieve co-delivery of paclitaxel(PTX)and doxorubicin(DOX)by pH-sensitive polyion complex micelles, and to evaluate its effects in vitro and in vivo. Methods Amphiphilic polyelectrolyte/prodrug micelles were constructed via synergistic electrostatic interactions between slightly positively charged pluronic F127-chitosan copolymer(F127-CS)and negatively charged cis-aconityl-doxorubicin(CA-DOX)prodrug. Mixed micelles were prepared using pluronic P105(P105)and F127-CS/CA-DOX, and poorly water-soluble anticancer drug PTX was incorporated into mixed micelles to realize the co-delivery of DOX and PTX. The particle size of micelles was measured and the critical micelle concentration(CMC)was observed by the pyrene fluorescence probe method. Finally, the characteristics of micelles such as in vitro drug release, in vitro cell uptake and in vivo pharmacodynamics studies were evaluated. Results The pH-sensitive micelles were prepared successfully. The average particle diameter of the micelles was 179.3 nm and the CMC was 0.039 mg/mL. DOX and PTX release from polymeric micelles followed a pH-dependent manner. The results of cell uptake studies exhibited that both DOX and PTX could be delivered into cells by P105/F127-CS/CA-DOX mixed micelles effectively. The in vivo pharmacodynamics studies of drug-loaded P105/F127-CS/CA-DOX micelles showed that the co-delivery micelles had a strong inhibitory effect on tumors with a lower toxicity. Conclusion The co-delivery micelles are pH-sensitive and have a strong inhibitory effect on cancer with a lower toxicity on normal tissues; it is potential for co-delivery of PTX and DOX.

Key words: Paclitaxel, Doxorubicin, Polyion complex micelles, Mixed micelles, Co-delivery, pH-sensitivity

CLC Number: 

  • R944.9
[1] 吕萍.化疗毒副作用及其人性化护理[J].护士进修杂志, 2008,23(3): 261-262.
[2] 吴亚琼,方伟蓉,李运曼.肿瘤多药耐药机制及逆转药物的研究进展[J].药学与临床研究, 2016, 24(1): 43-47. WU Yaqiong, FANG Weirong, LI Yunman. Mechanisms and reversing drugs of cancer multidrug resistance[J]. Pharmaceutical and Clinical Research, 2016, 24(1): 43-47.
[3] Ullah MF. Cancer multidrug resistance(MDR): a major impediment to effective chemotherapy[J]. Asian Pac J Cancer Prev, 2008, 9(1): 1-6.
[4] Polyak D, Eldar-Boock A, Baabur-Cohen H. Polymer conjugates for focal and targeted delivery of drugs[J]. Polym Adv Technol, 2013, 24(9): 777-790.
[5] Markovsky E, Baaburcohen H, Satchifainaro R. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs[J]. J Control Release, 2014, 187: 145-157.
[6] Rowinsky EK, Donehower RC, Jones RJ, et al. Microtubule changes and cytotoxicity in leukaemia cell lines treated with Taxol[J]. Cancer Res, 1988, 48(14): 4093-4100.
[7] Huang P, Wang W, Zhou J, et al. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery[J]. ACS Appl Mater Interfaces, 2015, 7(11): 6340-6350.
[8] Fornari FA, Randolph JK, Yalowich JC, et al. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells[J]. Molecular Pharmacology, 1994, 45(4): 649-656.
[9] Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin[J]. Biochem Pharmacol, 1999, 57(7): 727-741.
[10] Harada A, Kataoka K. Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block copolymers with poly(ethylene glycol)segments[J]. Macromolecules, 1995, 28(15): 5294-5299.
[11] Chen J, Ding J, Zhang Y, et al. Polyion complex micelles with gradient pH-sensitivity for adjustable intracellular drug delivery[J]. Polym Chem, 2014, 6(3): 397-405.
[12] 齐荣翔,崔汉钊,周海梅.用于药物递送的pH敏感聚合物研究进展[J].山东化工, 2016, 45(23): 72-75. QI Rongxiang, CUI Hanzhao, ZHOU Haimei. Recent progress of pH-sensitive polymers for drug delivery[J]. Shandong Chemical Industry, 2016, 45(23): 72-75.
[13] Gillies ER, Fréchet JM. pH-Responsive copolymer assemblies for controlled release of doxorubicin[J]. Bioconjug Chem, 2005, 16(2): 361-368.
[14] Lee ES, Oh KT, Kim D, et al. Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-histidine)[J]. J Control Release, 2007, 123(1): 19-26.
[15] Guan X, Li Y, Jiao Z, et al. A pH-sensitive charge-conversion system for doxorubicin delivery[J]. Acta Biomater, 2013, 9(8): 7672-7678.
[16] Son YJ, Jang JS, Cho YW, et al. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect[J]. J Control Release, 2003, 91(2): 135-145.
[17] Park KM, Joung YK, Park KD, et al. RGD-Conjugated chitosan-pluronic hydrogels as a cell supported scaffold for articular cartilage regeneration[J]. Macromol Res, 2008, 16(6): 517-523.
[18] Zhang W, Gilstrap K, Wu L, et al. Synthesis and characterization of thermally responsive Pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules[J]. Acs Nano, 2010, 4(11): 6747-6759.
[19] Liu Y, Sun J, Cao W, et al. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery[J]. Int J Pharm, 2011, 421(1): 160-169.
[20] Wang X, Cheng K, Han Y, et al. Effects of psoralen as an anti-tumor agent in human breast cancer MCF-7/ADR cells[J]. Biol Pharm Bull, 2016, 39(5): 815-822.
[21] Hu FQ, Liu LN, Du YZ, et al. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles[J]. Biomaterials, 2009, 30(36): 6955-6963.
[22] Du C, Deng D, Shan L, et al. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery[J]. Biomaterials, 2013, 34(12): 3087-3097.
[23] Chen L, Sha X, Jiang X, et al. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation[J]. Int J Nanomedicine, 2013, 8: 73-84.
[24] Zheng C, Yao X, Qiu L. Novel polymeric vesicles with pH-induced deformation character for advanced drug delivery[J]. Macromol Biosci, 2011, 11(3): 338-343.
[25] Gao Z, Zhang L, Sun Y. Nanotechnology applied to overcome tumor drug resistance[J]. J Control Release, 2012, 162(1): 45-55.
[1] ZHANG Shuying, WU Xiaofeng, GUO Limin, QIAO Wen, PENG Jieqiong, LI Daqing. Evaluation of two doxorubicin-induced heart failure models and changes of cardiac function [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 1-7.
[2] XING Deguang, MA Ermeng, WANG Moulong, SUN Zhongzheng, FAN Mingde, ZANG Yizheng, WANG Chengwei. Experimental research on biological activities of glioma cells inhibited by TRAIL in combination with paclitaxel [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(4): 12-15.
[3] ZHAO Yan-li1, HOU Zhun2, LI Yi-mu1, CUI Ya-nan1, LI Ling-bing1. Preparation and in vitro evaluation of paclitaxel-loaded mixed micelles [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(2): 58-64.
[4] SUN Gao-ying1, WANG Xiao-yuan2, ZHANG Xiao-jin1, HAO Xiu-yu1， GUO Yuan-fang1, WANG Xiao1, BI Wen-xiang1. Effects of N-acetylcysteine  on resistance to paclitaxel in cervical carcinoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 42-47.
[5] JIANG Xin1, GUO Wen-bin1, ZHU Mei1, LI Qiao1, JIANG Ting2, ZHANG Shuo1. Treatment effect of paclitaxel loaded microspheres in Skov3 tumor-bearing nude mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(1): 33-36.
[6] CUI Yanan1, GE Jianjun2, LI Lingbing1. Preparation of paclitaxel-loaded mixed micelles and
enhancement on oral absorption of paclitaxel [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(11): 107-112.
[7] WANG Jian1, WANG Xiu-wen1, WANG Ya-wei1, MA Dao-xin2, WANG Pu3. Paclitaxel-octreotide conjugates inhibit growth of human  small cell lung cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 27-32.
[8] WANG Jian1, WANG Xiu-wen1, WANG Ya-wei1, MA Dao-xin2, WANG Pu3. Paclitaxel-octreotide conjugates inhibit growth of human  small cell lung cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 27-32.
[9] LAI Zhen-nan， LIANG Rong， XIE Zhong， HUANG Jie. Radio-sensitization effect of paclitaxel versus sodium glycididazole for local advanced nasopharyngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(11): 131-134.
[10] MA Yun-bo, DING Sen-tai, LV Jia-ju. Intravesical instillation of pirarubicin combined with bacillus calmette-guerin in the prophylaxis of local recurrence after the resection of bladder cancer and the changes of urinary IL-8 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(2): 171-174.
[11] GAO Yan-hui,LI Bao-iu,GAN Yi-u,DONG Xin,CHENG Xiu-min,ZHAO Yan-biao. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(8): 823-826.
[12] LI Jun-ying,WU Xin-yi. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(11): 1164-1166.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd